Company Encyclopedia
View More
name
SPDR S&P SmallCap 600 ESG ETF
ESIX.US
News
View More

76,408 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Acquired by HBK Sorce Advisory LLC

HBK Sorce Advisory LLC acquired 76,408 shares of Arrowhead Pharmaceuticals, valued at approximately $2.82 million, during the 3rd quarter. This acquisition represents about 0.06% ownership in the company. Other institutional investors have also adjusted their positions in Arrowhead Pharmaceuticals. The stock's performance and analyst ratings indicate mixed sentiments, with some positive outlooks and insider sales noted.

Market Beat·
US
ARWR
+0.40%
Market Beat·
US
ARWR
+0.40%

Prudential is the best YTD performer among life and health insurance stocks

Prudential (PUK) leads the life and health insurance stocks with a YTD performance of +96.80%, making it the best performer in the sector. The S&P 500 financials sector has risen +14% YTD, ranking fourth in the S&P 500. Other top performers include Lincoln National (LNC) and Brighthouse Financial (BHF). Aegon (AEG) holds the highest Quant Rating of 4.69, despite ranking fifth.

businessinsider·
US
LNC
+0.52%
HK
02378
+0.83%
SG
K6S
0.00%
businessinsider·
US
LNC
+0.52%
HK
02378
+0.83%
SG
K6S
0.00%

Arrowhead Pharmaceuticals Chief Medical Officer Adeoye Y. Olukotun Reports Sale of Common Shares

Adeoye Y. Olukotun, Director at Arrowhead Pharmaceuticals Inc., has reported the sale of common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system.

Reuters·
US
ARWR
+0.40%
Reuters·
US
ARWR
+0.40%

InterDigital Director John A. Kritzmacher Reports Disposal of Common Shares

John A. Kritzmacher, Director at InterDigital Inc., has reported the disposal of common shares of the company. This event was disclosed through a filing on the EDGAR system by the U.S. Securities and Exchange Commission.

Reuters·
US
IDCC
+0.17%
Reuters·
US
IDCC
+0.17%

Lumen Technologies Subsidiary Secures $1.25 Billion in 8.5% Senior Notes Due 2036

Lumen Technologies' subsidiary, Level 3 Financing, Inc., has completed a $1.25 billion offering of 8.5% Senior Notes due 2036. The funds, along with cash on hand, were used to purchase existing second lien notes and amend indentures to remove restrictive covenants and release collateral. The transaction included a new indenture with U.S. Bank Trust Company as trustee. This financial move aims to optimize the company's debt structure.

Reuters·
US
LUMN
-0.26%
Reuters·
US
LUMN
-0.26%
© 2025 Longbridge｜Disclaimer